AstraZeneca Accused of Suppressing Negative Seroquel Study

By

Sarah Rubenstein

Mar 18, 2009 8:49 am ET

More details are trickling out from lawsuits over AstraZeneca’s antipsychotic Seroquel, including the latest on a clinical trial that the company allegedly put in a drawer after the results were unflattering.

The Washington Post details the journey of “Study 15″ in a front-page article this morning, reporting that AstraZeneca didn’t publish the study’s results or share them with doctors, even as it trumpeted less-rigorous studies …

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.